Clinical Trials in Tennessee

Showing 1641-1660 of 17,345 trials

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT07123454

This is a Phase I/II open-label, global multicenter study to evaluate the safety and efficacy of AZD4512 monotherapy or in combination with other anticancer agent(s), in participants with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (B-NHL).

B-cell Non-Hodgkin Lymphoma

AstraZeneca91 participantsStarted Sep 2025

Irvine, California, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +18 more locations

RECRUITINGPhase 1/229 miles

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

NCT05523947

This first-in-human study will be counducted to evaluate the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of YH32367 in Patients with HER2-Positive Locally Advanced or Metastatic Solid Tumors.

HER2-Positive Solid Tumor

Yuhan Corporation147 participantsStarted Aug 2022

Boston, Massachusetts, United States • Nashville, Tennessee, United States • Adelaide, Australia +16 more locations

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Find Trials by Condition in Tennessee

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

Evaluation of Clareon Vivity/Vivity Toric

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Prospective Study to Determine the Factors Influencing Infant Colic